Diagnosing cancer using histone modification analysis

Cancer Epigenetics

Volumn , Issue , 2008, Pages 347-357

  Verma, Mukesh ^a   Kumar, Deepak ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF THE DISTRICT OF COLUMBIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84862077656     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (105)

1. Verma, M., Maruvada, P., and Srivastava, S. 2004 Epigenetics and cancer. Crit Rev Clin Lab Sci, 41, 585-607
2. Jones, P.A. and Baylin, S.B. 2007 The epigenomics of cancer. Cell, 128, 683-692.
3. Ting, A.H., McGarvey, K.M., and Baylin, S.B. 2006 The cancer epigenome-components and functional correlates. Genes Dev, 20, 3215-3231.
4. Verma, M. and Manne, U. 2006 Genetic and epigenetic biomarkers in cancer diagnosis and identifying high risk populations. Crit Rev Oncol Hematol, 60, 9-18.
5. Verma, M., Seminara, D., Arena, F.J., John, C., Iwamoto, K., and Hartmuller, V. 2006 Genetic and epigenetic biomarkers in cancer: Improving diagnosis, risk assessment, and disease stratification. Mol Diagn & Ther, 10, 1-15.
6. Bernstein, B.E., Meissner, A., and Lander, E.S. 2007 The mammalian epigenome. Cell, 128, 669-681.
7. Gonzalo, S. and Blasco, M.A. 2005 Role of Rb family in the epigenetic definition of chromatin. Cell Cycle (Georgetown, Texas), 4, 752-755.
8. Gonzalo, S., Garcia-Cao, M., Fraga, M.F., Schotta, G., Peters, A.H., Cotter, S.E., Eguia, R., Dean, D.C., Esteller, M., Jenuwein, T., and Blasco, M.A. 2005 Role of the RB1 family in stabilizing histone methylation at constitutive heterochromatin. Nat Cell Biol, 7, 420-428.
9. Pogribny, I.P., Ross, S.A., Tryndyak, V.P., Pogribna, M., Poirier, L.A., and Karpinets, T.V. 2006 Histone H3 lysine 9 and H4 lysine 20 trimethylation and the expression of Suv4-20h2 and Suv-39h1 histone methyltransferases in hepatocarcinogenesis induced by methyl deficiency in rats. Carcinogenesis, 27, 1180-1186.
10. Tryndyak, V.P., Kovalchuk, O., and Pogribny, I.P. 2006 Loss of DNA methylation and histone H4 lysine 20 trimethylation in human breast cancer cells is associated with aberrant expression of DNA methyltransferase 1, Suv4-20h2 histone methyltransferase and methyl-binding proteins. Cancer Biol Ther, 5, 65-70.
11. Tryndyak, V.P., Muskhelishvili, L., Kovalchuk, O., Rodriguez-Juarez, R., Montgomery, B., Churchwell, M.I., Ross, S.A., Beland, F.A., and Pogribny, I.P. 2006 Effect of long-term tamoxifen exposure on genotoxic and epigenetic changes in rat liver: Implications for tamoxifen-induced hepatocarcinogenesis. Carcinogenesis, 27, 1713-1720.
12. Beck, H.C., Nielsen, E.C., Matthiesen, R., Jensen, L.H., Sehested, M., Finn, P., Grauslund, M., Hansen, A.M., and Jensen, O.N. 2006 Quantitative proteomic analysis of post-translational modifications of human histones. Mol Cell Proteomics, 5, 1314-1325.
13. Seligson, D.B., Horvath, S., Shi, T., Yu, H., Tze, S., Grunstein, M., and Kurdistani, S.K. 2005 Global histone modification patterns predict risk of prostate cancer recurrence. Nature, 435, 1262-1266.
14. Isaac, C.E., Francis, S.M., Martens, A.L., Julian, L.M., Seifried, L.A., Erdmann, N., Binne, U.K., Harrington, L., Sicinski, P., Berube, N.G., Dyson, N.J., and Dick, F.A. 2006 The retinoblastoma protein regulates pericentric heterochromatin. Mol Cell Biol, 26, 3659-3671.
15. Verdone, L., Wu, J., van Riper, K., Kacherovsky, N., Vogelauer, M., Young, E.T., Grunstein, M., Di Mauro, E., and Caserta, M. 2002 Hyperacetylation of chromatin at the ADH2 promoter allows Adr1 to bind in repressed conditions. EMBO J, 21, 1101-1111.
16. Vogelauer, M., Wu, J., Suka, N., and Grunstein, M. 2000 Global histone acetylation and deacetylation in yeast. Nature, 408, 495-498.
17. Seligson, D., Horvath, S., Huerta-Yepez, S., Hanna, S., Garban, H., Roberts, A., Shi, T., Liu, X., Chia, D., Goodglick, L., and Bonavida, B. 2005 Expression of transcription factor Yin Yang 1 in prostate cancer. Int J Oncol, 27, 131-141.
18. Kogai, T., Hershman, J.M., Motomura, K., Endo, T., Onaya, T., and Brent, G.A. 2001 Differential regulation of the human sodium/iodide symporter gene promoter in papillary thyroid carcinoma cell lines and normal thyroid cells. Endocrinology, 142, 3369-3379.
19. Polo, S.E. and Almouzni, G. 2005 Histone metabolic pathways and chromatin assembly factors as proliferation markers. Cancer Lett, 220, 1-9.
20. Bolden, J.E., Peart, M.J., and Johnstone, R.W. 2006 Anticancer activities of histone deacetylase inhibitors. Nature Reviews, 5, 769-784.
21. Nightingale, K.P., O'Neill, L.P., and Turner, B.M. 2006 Histone modifications: Signalling receptors and potential elements of a heritable epigenetic code. Curr Opin Genet Dev, 16, 125-136.
22. Nguyen, T.T., Cho, K., Stratton, S.A., and Barton, M.C. 2005 Transcription factor interactions and chromatin modifications associated with p53-mediated, developmental repression of the alpha-fetoprotein gene. Mol Cell Biol, 25, 2147-2157.
23. Rando, O.J. 2007 Global patterns of histone modifications. Curr Opin Gen Dev, 17, 94-99.
24. Marte, B. 2005 Cancer: A changing global view. Nature, 435, 1172.
25. An, W. 2007 Histone acetylation and methylation: Combinatorial players for transcriptional regulation. SubCell Biochem, 41, 351-369.
26. He, S., Dunn, K.L., Espino, P.S., Drobic, B., Li, L., Yu, J., Sun, J.M., Chen, H.Y., Pritchard, S., and Davie, J.R. 2007 Chromatin organization and nuclear microenvironments in cancer cells. J Cell Biochem, 104, 2004-2015.
27. Kondo, Y., Shen, L., Suzuki, S., Kurokawa, T., Masuko, K., Tanaka, Y., Kato, H., Mizuno, Y., Yokoe, M., Sugauchi, F., Hirashima, N., Orito, E., Osada, H., Ueda, R., Guo, Y., Chen, X., Issa, J.P., and Sekido, Y. 2007 Alterations of DNA methylation and histone modifications contribute to gene silencing in hepatocellular carcinomas. Hepatol Res, 37, 974-983.
28. Kurdistani, S.K. 2007 Histone modifications as markers of cancer prognosis: A cellular view. Br J Cancer, 97, 1-5.
29. Orr, J.A. and Hamilton, P.W. 2007 Histone acetylation and chromatin pattern in cancer. A review. Analytical and Quantitative Cytology and Histology/the International Academy of Cytology [and] American Society of Cytology, 29, 17-31.
30. Provenzano, M.J. and Domann, F.E. 2007 A role for epigenetics in hearing: Establishment and maintenance of auditory specific gene expression patterns. Hear Res, 233, 1-13.
31. Trtkova, K., Bouchal, J., and Kolar, Z. 2007 Histone acetylation and methylation in the signaling of steroid hormone receptors. Cell Mol Biol (Noisy-le-Grand, France), 53 Suppl, OL930-OL942.
32. Wischnewski, F., Pantel, K., and Schwarzenbach, H. 2006 Promoter demethylation and histone acetylation mediate gene expression of MAGE-A1, -A2, -A3, and -A12 in human cancer cells. Mol Cancer Res, 4, 339-349.
33. Thomas, N.R. 2006 Histone post-translational modification: From discovery to the clinic. IDrugs, 9, 398-401.
34. Verdone, L., Agricola, E., Caserta, M., and Di Mauro, E. 2006 Histone acetylation in gene regulation. Brief Funct Genomic Proteomic, 5, 209-221.
35. Wu, J., Wang, S.H., Potter, D., Liu, J.C., Smith, L.T., Wu, Y.Z., Huang, T.H., and Plass, C. 2007 Diverse histone modifications on histone 3 lysine 9 and their relation to DNA methylation in specifying gene silencing. BMC Genomics, 8, 131.
36. Santini, V., Gozzini, A., and Ferrari, G. 2007 Histone deacetylase inhibitors: Molecular and biological activity as a premise to clinical application. Curr Drug Metab, 8, 383-393.
37. Broide, R.S., Redwine, J.M., Aftahi, N., Young, W., Bloom, F.E., and Winrow, C.J. 2007 Distribution of histone deacetylases 1-11 in the rat brain. J Mol Neurosci, 31, 47-58.
38. Qian, D.Z., Kachhap, S.K., Collis, S.J., Verheul, H.M., Carducci, M.A., Atadja, P., and Pili, R. 2006 Class II histone deacetylases are associated with VHL-independent regulation of hypoxia-inducible factor 1####alpha#####. Cancer Res, 66, 8814-8821.
39. Osada, H., Tatematsu, Y., Saito, H., Yatabe, Y., Mitsudomi, T., and Takahashi, T. 2004 Reduced expression of class II histone deacetylase genes is associated with poor prognosis in lung cancer patients. Int J Cancer, 112, 26-32.
40. Barski, A., Cuddapah, S., Cui, K., Roh, T.Y., Schones, D.E., Wang, Z., Wei, G., Chepelev, I., and Zhao, K. 2007 High-resolution profiling of histone methylations in the human genome. Cell, 129, 823-837.
41. Osada, S. 2007 Histone modification enzymes induced during chemical hepatocarcinogenesis. Yakugaku Zasshi, 127, 469-479.
42. Zhu, X., Lee, K., Asa, S.L., and Ezzat, S. 2007 Epigenetic silencing through DNA and histone methylation of fibroblast growth factor receptor 2 in neoplastic pituitary cells. Am J Pathol, 170, 1618-1628.
43. Brueckner, B., Kuck, D., and Lyko, F. 2007 DNA methyltransferase inhibitors for cancer therapy. Cancer J, 13, 17-22.
44. Eoli, M., Menghi, F., Bruzzone, M.G., De Simone, T., Valletta, L., Pollo, B., Bissola, L., Silvani, A., Bianchessi, D., D'Incerti, L., Filippini, G., Broggi, G., Boiardi, A., and Finocchiaro, G. 2007 Methylation of O6-methylguanine DNA methyltransferase and loss of heterozygosity on 19q and/or 17p are overlapping features of secondary glioblastomas with prolonged survival. Clin Cancer Res, 13, 2606-2613.
45. Fanelli, M., Caprodossi, S., Ricci-Vitiani, L., Porcellini, A., Tomassoni-Ardori, F., Amatori, S., Andreoni, F., Magnani, M., De Maria, R., Santoni, A., Minucci, S., and Pelicci, P.G. 2008 Loss of pericentromeric DNA methylation pattern in human glioblastoma is associated with altered DNA methyltransferases expression and involves the stem cell compartment. Oncogene, 27, 358-365.
46. Ghoshal, K. and Bai, S. 2007 DNA methyltransferases as targets for cancer therapy. Drugs Today (Barc), 43, 395-422.
47. Menigatti, M., Pedroni, M., Verrone, A.M., Borghi, F., Scarselli, A., Benatti, P., Losi, L., Di Gregorio, C., Schar, P., Marra, G., Ponz de Leon, M., and Roncucci, L. 2007 O6-methylguanine-DNA methyltransferase promoter hypermethylation in colorectal carcinogenesis. Oncol Rep, 17, 1421-1427.
48. Murakami, J., Lee, Y.J., Kokeguchi, S., Tsujigiwa, H., Asaumi, J., Nagatsuka, H., Fukui, K., Kuroda, M., Tanaka, N., and Matsubara, N. 2007 Depletion of O6-methylguanine-DNA methyltransferase by O6-benzylguanine enhances 5-FU cytotoxicity in colon and oral cancer cell lines. Oncol Rep, 17, 1461-1467.
49. Ouerhani, S., Oliveira, E., Marrakchi, R., Ben Slama, M.R., Sfaxi, M., Ayed, M., Chebil, M., Amorim, A., El Gaaied, A.B., and Prata, M.J. 2007 Methylenetetrahydrofolate reductase and methionine synthase polymorphisms and risk of bladder cancer in a Tunisian population. Cancer Genet Cytogenet, 176, 48-53.
50. Hirota, T., Lipp, J.J., Toh, B.H., and Peters, J.M. 2005 Histone H3 serine 10 phosphorylation by Aurora B causes HP1 dissociation from heterochromatin. Nature, 438, 1176-1180.
51. Lee, E.C., Frolov, A., Li, R., Ayala, G., and Greenberg, N.M. 2006 Targeting Aurora kinases for the treatment of prostate cancer. Cancer Res, 66, 4996-5002.
52. Li, Y., Kao, G.D., Garcia, B.A., Shabanowitz, J., Hunt, D.F., Qin, J., Phelan, C., and Lazar, M.A. 2006 A novel histone deacetylase pathway regulates mitosis by modulating Aurora B kinase activity. Genes Dev, 20, 2566-2579.
53. Monier, K., Mouradian, S., and Sullivan, K.F. 2007 DNA methylation promotes Aurora-B-driven phosphorylation of histone H3 in chromosomal subdomains. J Cell Sci, 120, 101-114.
54. Sistayanarain, A., Tsuneyama, K., Zheng, H., Takahashi, H., Nomoto, K., Cheng, C., Murai, Y., Tanaka, A., and Takano, Y. 2006 Expression of Aurora-B kinase and phosphorylated histone H3 in hepatocellular carcinoma. Anticancer Res, 26, 3585-3593.
55. Wang, Q., Wang, C.M., Ai, J.S., Xiong, B., Yin, S., Hou, Y., Chen, D.Y., Schatten, H., and Sun, Q.Y. 2006 Histone phosphorylation and pericentromeric histone modifications in oocyte meiosis. Cell Cycle, 5, 1974-1982.
56. Ura, S., Nishina, H., Gotoh, Y., and Katada, T. 2007 Activation of the c-Jun N-terminal kinase pathway by MST1 is essential and sufficient for the induction of chromatin condensation during apoptosis. Mol Cell Biol, 27, 5514-5522.
57. Giannattasio, M., Lazzaro, F., Plevani, P., and Muzi-Falconi, M. 2005 The DNA damage checkpoint response requires histone H2B ubiquitination by Rad6-Bre1 and H3 methylation by Dot1. J Biol Chem, 280, 9879-9886.
58. Zhang, X., Kolaczkowska, A., Devaux, F., Panwar, S.L., Hallstrom, T.C., Jacq, C., and Moye-Rowley, W.S. 2005 Transcriptional regulation by Lge1p requires a function independent of its role in histone H2B ubiquitination. J Biol Chem, 280, 2759-2770.
59. Gayther, S.A., Batley, S.J., Linger, L., Bannister, A., Thorpe, K., Chin, S.F., Daigo, Y., Russell, P., Wilson, A., Sowter, H.M., Delhanty, J.D., Ponder, B.A., Kouzarides, T., and Caldas, C. 2000 Mutations truncating the EP300 acetylase in human cancers. Nat Genet, 24, 300-303.
60. Boix-Chornet, M., Fraga, M.F., Villar-Garea, A., Caballero, R., Espada, J., Nunez, A., Casado, J., Largo, C., Casal, J.I., Cigudosa, J.C., Franco, L., Esteller, M., and Ballestar, E. 2006 Release of hypoacetylated and trimethylated histone H4 is an epigenetic marker of early apoptosis. J Biol Chem, 281, 13540-13547.
61. Fraga, M.F., Ballestar, E., Paz, M.F., Ropero, S., Setien, F., Ballestar, M.L., Heine-Suner, D., Cigudosa, J.C., Urioste, M., Benitez, J., Boix-Chornet, M., Sanchez-Aguilera, A., Ling, C., Carlsson, E., Poulsen, P., Vaag, A., Stephan, Z., Spector, T.D., Wu, Y.Z., Plass, C., and Esteller, M. 2005 Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci U S A, 102, 10604-10609.
62. Fraga, M.F., Ballestar, E., Villar-Garea, A., Boix-Chornet, M., Espada, J., Schotta, G., Bonaldi, T., Haydon, C., Ropero, S., Petrie, K., Iyer, N.G., Perez-Rosado, A., Calvo, E., Lopez, J.A., Cano, A., Calasanz, M.J., Colomer, D., Piris, M.A., Ahn, N., Imhof, A., Caldas, C., Jenuwein, T., and Esteller, M. 2005 Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer. Nat Genet, 37, 391-400.
63. Idikio, H.A. 2006 Spindle checkpoint protein hMad2 and histone H3 phosphoserine 10 mitosis marker in pediatric solid tumors. Anticancer Res, 26, 4687-4694.
64. Nguyen, C.T., Weisenberger, D.J., Velicescu, M., Gonzales, F.A., Lin, J.C., Liang, G., and Jones, P.A. 2002 Histone H3-lysine 9 methylation is associated with aberrant gene silencing in cancer cells and is rapidly reversed by 5-aza-2'-deoxycytidine. Cancer Res, 62, 6456-6461.
65. Zhang, Z., Yamashita, H., Toyama, T., Sugiura, H., Omoto, Y., Ando, Y., Mita, K., Hamaguchi, M., Hayashi, S., and Iwase, H. 2004 HDAC6 expression is correlated with better survival in breast cancer. Clin Cancer Res, 10, 6962-6968.
66. Saji, S., Kawakami, M., Hayashi, S., Yoshida, N., Hirose, M., Horiguchi, S., Itoh, A., Funata, N., Schreiber, S.L., Yoshida, M., and Toi, M. 2005 Significance of HDAC6 regulation via estrogen signaling for cell motility and prognosis in estrogen receptor-positive breast cancer. Oncogene, 24, 4531-4539.
67. Siddiqui, H., Fox, S.R., Gunawardena, R.W., and Knudsen, E.S. 2007 Loss of RB compromises specific heterochromatin modifications and modulates HP1alpha dynamics. J Cell Physiol, 211, 131-137.
68. Krusche, C.A., Wulfing, P., Kersting, C., Vloet, A., Bocker, W., Kiesel, L., Beier, H.M., and Alfer, J. 2005 Histone deacetylase-1 and -3 protein expression in human breast cancer: A tissue microarray analysis. Breast Cancer Res Treat, 90, 15-23.
69. Zhang, Z., Yamashita, H., Toyama, T., Sugiura, H., Ando, Y., Mita, K., Hamaguchi, M., Hara, Y., Kobayashi, S., and Iwase, H. 2005 Quantitation of HDAC1 mRNA expression in invasive carcinoma of the breast. Breast Cancer Res Treat, 94, 11-16.
70. Anton, M., Horky, M., Kuchtickova, S., Vojtesek, B., and Blaha, O. 2004 Immunohistochemical detection of acetylation and phosphorylation of histone H3 in cervical smears. Ceska gynekologie/Ceska lekarska spolecnost J Ev, 69, 3-6.
71. Duenas-Gonzalez, A., Lizano, M., Candelaria, M., Cetina, L., Arce, C., and Cervera, E. 2005 Epigenetics of cervical cancer. An overview and therapeutic perspectives. Mol Cancer, 4, 38.
72. Kondo, Y., Shen, L., Yan, P.S., Huang, T.H., and Issa, J.P. 2004 Chromatin immunoprecipitation microarrays for identification of genes silenced by histone H3 lysine 9 methylation. Proc Natl Acad Sci USA, 101, 7398-7403.
73. Kondo, Y. and Issa, J.P. 2004 Epigenetic changes in colorectal cancer. Cancer Metastasis Rev, 23, 29-39.
74. Tzao, C., Sun, G.H., Tung, H.J., Hsu, H.S., Hsu, W.H., Wang, Y.C., Cheng, Y.L., and Lee, S.C. 2006 Reduced acetylated histone H4 is associated with promoter methylation of the fragile histidine triad gene in resected esophageal squamous cell carcinoma. Ann Thorac Sur, 82, 396-401; discussion 401.
75. Toh, Y., Ohga, T., Endo, K., Adachi, E., Kusumoto, H., Haraguchi, M., Okamura, T., and Nicolson, G.L. 2004 Expression of the metastasis-associated MTA1 protein and its relationship to deacetylation of the histone H4 in esophageal squamous cell carcinomas. Int J Cancer, 110, 362-367.
76. Yasui, W., Sentani, K., Motoshita, J., and Nakayama, H. 2006 Molecular pathobiology of gastric cancer. Scand J Surg, 95, 225-231.
77. Youssef, E.M., Issa, J.P., and Lotan, R. 2004 Regulation of RARbeta1 expression in head and neck cancer cells by cell density-dependent chromatin remodeling. Cancer Biol Ther, 3, 1002-1006.
78. Ogawa, M., Sakashita, K., Zhao, X.Y., Hayakawa, A., Kubota, T., and Koike, K. 2007 Analysis of histone modification around the CpG island region of the p15 gene in acute myeloblastic leukemia. Leuk Res, 31, 611-621.
79. Linggi, B.E., Brandt, S.J., Sun, Z.W., and Hiebert, S.W. 2005 Translating the histone code into leukemia. J Cell Bioch, 96, 938-950.
80. Lukasova, E., Koristek, Z., Falk, M., Kozubek, S., Grigoryev, S., Kozubek, M., Ondrej, V., and Kroupova, I. 2005 Methylation of histones in myeloid leukemias as a potential marker of granulocyte abnormalities. J Leukoc Biol, 77, 100-111.
81. Karaczyn, A.A., Golebiowski, F., and Kasprzak, K.S. 2006 Ni(II) affects ubiquitination of core histones H2B and H2A. Exp Cell Res, 312, 3252-3259.
82. Caslini, C., Capo-chichi, C.D., Roland, I.H., Nicolas, E., Yeung, A.T., and Xu, X.X. 2006 Histone modifications silence the GATA transcription factor genes in ovarian cancer. Oncogene, 25, 5446-5461.
83. Orhan, D., Kale, G., Caglar, M., Gogus, S., and Karaagaoglu, E. 2006 Histone mRNA in situ hybridization and Ki 67 immunohistochemistry in pediatric adrenocortical tumors. Virchows Arch, 448, 591-596.
84. Manoharan, M., Ramachandran, K., Soloway, M.S., and Singal, R. 2007 Epigenetic targets in the diagnosis and treatment of prostate cancer. Int Braz J Urol, 33, 11-18.
85. Dobosy, J.R., Roberts, J.L., Fu, V.X., and Jarrard, D.F. 2007 The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia. J Urol, 177, 822-831.
86. Schulz, W.A. and Hatina, J. 2006 Epigenetics of prostate cancer: Beyond DNA methylation. J Cell Mol Med, 10, 100-125.
87. Li, L.C., Carroll, P.R., and Dahiya, R. 2005 Epigenetic changes in prostate cancer: Implication for diagnosis and treatment. J Natl Cancer Inst, 97, 103-115.
88. Kahl, P., Gullotti, L., Heukamp, L.C., Wolf, S., Friedrichs, N., Vorreuther, R., Solleder, G., Bastian, P.J., Ellinger, J., Metzger, E., Schule, R., and Buettner, R. 2006 Androgen receptor coactivators lysine-specific histone demethylase 1 and four and a half LIM domain protein 2 predict risk of prostate cancer recurrence. Cancer Res, 66, 11341-11347.
89. Fraga, M.F., Agrelo, R., and Esteller, M. 2007 Cross-talk between aging and cancer: The epigenetic language. Ann N Y Acad Sci, 1100, 60-74.
90. Fraga, M.F. and Esteller, M. 2005 Towards the human cancer epigenome: A first draft of histone modifications. Cell Cycle, 4, 1377-1381.
91. Fraga, M.F. and Esteller, M. 2007 Epigenetics and aging: The targets and the marks. Trends Genet, 23, 413-418.
92. Olins, D.E. and Olins, A.L. 2005 Granulocyte heterochromatin: Defining the epigenome. BMC Cell Biol, 6, 39.
93. Ono, S., Oue, N., Kuniyasu, H., Suzuki, T., Ito, R., Matsusaki, K., Ishikawa, T., Tahara, E., and Yasui, W. 2002 Acetylated histone H4 is reduced in human gastric adenomas and carcinomas. J Exp Clin Cancer Res, 21, 377-382.
94. Sarg, B., Koutzamani, E., Helliger, W., Rundquist, I., and Lindner, H.H. 2002 Postsynthetic trimethylation of histone H4 at lysine 20 in mammalian tissues is associated with aging. J Biol Chem, 277, 39195-39201.
95. Toh, Y., Yamamoto, M., Endo, K., Ikeda, Y., Baba, H., Kohnoe, S., Yonemasu, H., Hachitanda, Y., Okamura, T., and Sugimachi, K. 2003 Histone H4 acetylation and histone deacetylase 1 expression in esophageal squamous cell carcinoma. Oncol Rep, 10, 333-338.
96. Yan, N. and Shi, Y. 2003 Histone H1.2 as a trigger for apoptosis. Nat Struct Biol, 10, 983-985.
97. Yan, Q., Huang, J., Fan, T., Zhu, H., and Muegge, K. 2003 Lsh, a modulator of CpG methylation, is crucial for normal histone methylation. EMBO J, 22, 5154-5162.
98. Yasui, W., Oue, N., Ono, S., Mitani, Y., Ito, R., and Nakayama, H. 2003 Histone acetylation and gastrointestinal carcinogenesis. Ann N Y Acad Sci, 983, 220-231.
99. Verma, M. 2003 Viral genes and methylation. Ann N Y Acad Sci, 983, 170-180.
100. Verma, M., Dunn, B.K., Ross, S., Jain, P., Wang, W., Hayes, R., and Umar, A. 2003 Early detection and risk assessment: Proceedings and recommendations from the Workshop on Epigenetics in Cancer Prevention. Ann N Y Acad Sci, 983, 298-319.
101. Verma, M. and Srivastava, S. 2002 Epigenetics in cancer: Implications for early detection and prevention. Lancet Oncol, 3, 755-763.
102. Ronzoni, S., Faretta, M., Ballarini, M., Pelicci, P., and Minucci, S. 2005 New method to detect histone acetylation levels by flow cytometry. Cytometry A, 66, 52-61.
103. Ho, S.M. and Tang, W.Y. 2007 Techniques used in studies of epigenome dysregulation due to aberrant DNA methylation: An emphasis on fetal-based adult diseases. Reprod Toxicol, 23, 267-282.
104. Sarg, B., Helliger, W., Talasz, H., Koutzamani, E., and Lindner, H.H. 2004 Histone H4 hyperacetylation precludes histone H4 lysine 20 trimethylation. J Biol Chem, 279, 53458-53464.
105. Zhang, L., Freitas, M.A., Wickham, J., Parthun, M.R., Klisovic, M.I., Marcucci, G., and Byrd, J.C. 2004 Differential expression of histone post-translational modifications in acute myeloid and chronic lymphocytic leukemia determined by high-pressure liquid chromatography and mass spectrometry. J Am Soc Mass Spectrom, 15, 77-86.